Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 Life Science Investing
Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 Life Science Investing
OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer Life Science Investing
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease Life Science Investing
ARS Pharmaceuticals to Showcase Scientific Innovation and Robust Clinical Data on neffy® at 2026 American Academy of Allergy, Asthma and Immunology Annual Scientific Meeting Life Science Investing
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 Biotech Investing
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 Life Science Investing
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
